[The cornea and synthetic antimalarials].
The main targets of antimalarial ocular toxicity are the cornea, ciliary body and retina. In sixty patients treated with chloroquine (Nivaquine) 73% showed keratopathy. The clinical features and clinical course of this keratopathy and its relationship with retinopathy were described. In contrast with retinopathy, keratopathy is not contraindication to antimalarial treatment.
Jeddi
A
A
Institut Hédi Rais d'Ophtalmologie, Tunis, Tunisie.
Ben Osman
N
N
Daghfous
F
F
Bouguila
H
H
Charfi
O
O
Ayed
S
S
D000293:Adolescent; D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects; D003316:Corneal Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000139:chemically induced / Q000503:physiopathology; D012307:Risk Factors
D000962:Antimalarials; D002738:Chloroquine
Cornée et antipaludéens de synthèse.